Workflow
离焦软镜
icon
Search documents
7岁女童配眼镜度数被搞反,佩戴10个月视力骤降!眼镜店:配错原因内部在调查
Xin Lang Cai Jing· 2026-01-10 14:19
Group 1 - A mother in Wuhan reported that her daughter's glasses were incorrectly fitted, leading to a rapid deterioration in her vision, consuming four years of far-sightedness reserve in just one year [1] - The optical store has agreed to compensate the mother with 20,000 yuan after negotiations [2] Group 2 - The increasing prevalence of electronic devices in children's lives has made selecting appropriate glasses a necessity for many parents, emphasizing the importance of myopia control glasses [3] - Myopia control glasses are categorized into four main types based on their mechanisms and wearing methods: defocus glasses, contrast-reducing glasses, orthokeratology lenses, and defocus soft lenses [3][4][6][7] - Defocus glasses are the primary method for myopia control, showing a 60% rate of myopia progression delay in clinical observations [3][6] - Contrast-reducing glasses utilize point spread technology to lower retinal contrast, which may help in delaying myopia progression [4][5] - Orthokeratology lenses, worn overnight, temporarily reshape the cornea to correct myopia, allowing clear vision during the day without glasses [6] - Defocus soft lenses are a newer method suitable for children who cannot wear orthokeratology lenses, with a myopia progression delay rate of 50%-60% [7] - Effective myopia prevention requires a multifaceted approach, with proper eye habits being fundamental alongside the use of glasses [7]
全国爱眼日:近视防控不焦虑,精准评估·个性方案·动态追踪
Ren Min Wang· 2025-05-28 01:52
Group 1 - The core viewpoint emphasizes the importance of controlling the progression of myopia in children rather than attempting to reverse it, as most optical methods can only slow down the increase in myopia [2][3] - For children around the age of 10 with myopia under 100 degrees, optical methods like functional frame glasses and OK lenses may show some cases of myopia regression, but this is not common [2] - It is crucial to conduct cycloplegic refraction tests to accurately assess myopia, as traditional vision tests may not detect low degrees of myopia in children who still have normal visual acuity [3] Group 2 - For children who have already developed myopia, intervention measures should be tailored based on the degree of myopia and astigmatism, as well as the individual child's situation [3] - Functional frame glasses or OK lenses are recommended for children with relatively low myopia and high astigmatism, but adjustments should be made based on the child's response and axial growth [3] - Children with low myopia or pure astigmatism may be better suited to wear frame glasses [3]
爱博医疗(688050):25Q1业绩短期承压 期待PR等新业务放量
Xin Lang Cai Jing· 2025-04-29 02:40
Core Viewpoint - The company reported strong revenue growth in 2024, but faced a decline in net profit in Q1 2025 due to market pressures from centralized procurement and reduced surgical volumes [1][2]. Financial Performance - In 2024, the company achieved revenue of 1.41 billion yuan, a year-on-year increase of 48.24%, and a net profit of 388 million yuan, up 27.77% [1]. - For Q1 2025, revenue was 357 million yuan, reflecting a year-on-year growth of 15.07%, while net profit decreased to 93 million yuan, down 10.05% [1]. Product Performance - Revenue from artificial crystalline lenses reached 588 million yuan in 2024, growing by 17.66%, with sales volume increasing by 44.93% [2]. - The company’s revenue from myopia control products grew by 20.79%, driven by the introduction of various new products [2]. R&D Investment and New Business Growth - The company increased R&D investment to 160 million yuan in 2024, a rise of 20.80%, representing 11.33% of total revenue [3]. - The contact lens business saw significant growth, with revenue reaching 426 million yuan, a staggering increase of 211.84% [3]. Market Outlook - The company is projected to achieve revenues of 1.81 billion yuan, 2.26 billion yuan, and 2.79 billion yuan for 2025-2027, with respective growth rates of 28.44%, 24.91%, and 23.12% [4]. - Expected net profits for the same period are 467 million yuan, 600 million yuan, and 778 million yuan, with growth rates of 20.21%, 28.55%, and 29.63% [4]. Earnings Per Share - The projected EPS for the years 2025, 2026, and 2027 are 2.46 yuan, 3.17 yuan, and 4.10 yuan respectively [5].